Повысь уровень инвестиционной грамотности и стань профессионалом с курсами от Societe Financiers!Подробнее

Xenon Pharmaceuticals  logo
Xenon Pharmaceuticals XENE
€ 26.59 -4.27%

Geschäftsbericht 2024
hinzugefügt 27.02.2025

report update icon

Xenon Pharmaceuticals Kennzahlen 2011-2025 | XENE

Kennzahlen Jährlich Xenon Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-12.8 -17.2 -19.6 -15.0 -17.2 -9.3 -4.6 -1.8 -5.4 -6.0 4.3 - - -

P/S

- - 260.1 64.2 15.4 56.7 - 179.3 69.2 6.1 2.0 - - -

EPS

-3.0 -2.7 -2.1 -1.8 -0.8 -1.5 -1.6 -1.7 -1.5 -1.1 4.1 2.9 -3.2 -

EV (Enterprise Value)

2.9 B 3.02 B 2.43 B 1.03 B 469 M 418 M 111 M 45.5 M 111 M 38.7 M -1.07 M -7.58 M -9.48 M -

EBITDA per Share

-3.55 -3.17 -2.11 -1.79 -0.89 -1.63 -1.93 -1.78 -1.55 -0.583 3.74 - - -

EV/EBITDA

-13.1 -14.9 -8.9 -2.8 -1.3 -4.5 -4.3 -1.3 - - -

PEG

-0.47 -0.79 -1.46 -1.18 -0.67 -1.69 -0.99 0.12 0.16 0.05 0.02 - - -

P/B

4.0 3.4 3.4 2.2 2.9 4.2 1.5 1.6 2.0 1.5 0.8 - - -

P/CF

-16.5 -20.7 -24.3 -17.0 -10.3 -65.9 -4.5 -1.9 -6.3 -5.1 -44.6 - - -

ROE %

-31.04 -19.66 -17.38 -14.34 -16.83 -45.22 -33.40 -85.45 -35.99 -25.81 17.89 - - -

ROA %

-29.36 -18.90 -16.62 -13.79 -15.24 -28.16 -28.18 -66.57 -34.08 -24.63 14.89 - - -

ROCE %

-37.00 -23.07 -17.90 -14.36 -18.27 -41.05 -32.13 -77.49 -38.79 -15.30 15.19 - - -

Current Ratio

18.5 26.2 23.1 26.0 10.6 3.3 29.5 11.0 18.7 21.9 5.9 - - -

DSO

- - 72.6 45.4 15.0 43.5 - 514.1 40.5 7.4 2.8 - - -

DIO

- - - - - - - - - - - - - -

DPO

- - - - - - 40.5 - - - - - - -

Betriebszyklus

- - 72.6 45.4 14.9 - - - - - - - - -

Finanzkreislauf

- - 72.6 45.4 14.9 - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Xenon Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.81 -0.75 -0.62 - -0.73 -0.72 -0.63 - -0.57 -0.55 -0.35 - -0.36 -0.51 -0.42 - -0.25 - -0.22 - -0.33 -0.37 -0.42 - -0.63 -0.45 -0.21 -0.45 -0.43 -0.41 -0.42 -0.34 -0.51 -0.42 -0.23 -0.27 -0.27 0.08 -0.64 0.14 2.67 - - 1.87 0.99 - - - - - - - - - -

EBITDA per Share

- - -0.75 - - - -0.74 - -0.57 -0.53 -0.31 - -0.35 -0.52 -0.43 - -0.26 -0.01 -0.24 - -0.34 -0.4 -0.45 - -0.68 -0.51 -0.43 -0.45 -0.45 -0.42 -0.44 -0.3 -0.43 -0.4 -0.37 -0.18 - 0.05 -0.42 - 6.82 1.28 0.9 1.5 5.27 - - - - - - - - - -

ROE %

-27.75 -27.49 -27.97 -21.03 -25.96 -23.28 -19.91 -12.53 -18.73 -20.00 -24.64 -20.51 -25.68 -24.64 -16.14 -9.64 -19.28 -23.76 -34.54 -32.85 -46.78 -51.06 -47.73 -25.11 -47.56 -119.08 -196.97 -278.78 -265.73 -216.28 -166.82 -117.36 -114.42 -104.24 -94.06 -83.88 -75.74 -32.05 11.65 55.34 50.45 17.21 -0.67 -18.56 -15.35 - - - - - - - - - -

ROA %

-26.50 -26.21 -26.59 -19.95 -24.74 -22.30 -19.23 -12.17 -18.01 -19.07 -23.26 -19.31 -23.99 -22.83 -14.88 -8.73 -14.74 -16.06 -22.74 -20.46 -32.21 -37.95 -37.55 -21.19 -38.67 -93.50 -153.70 -217.20 -208.61 -176.12 -143.62 -111.13 -108.39 -98.94 -89.50 -80.05 -72.50 -32.97 6.55 46.08 49.29 56.48 41.59 26.70 22.08 - - - - - - - - - -

ROCE %

-32.82 -32.33 -32.75 -24.49 -29.55 -25.87 -21.12 -12.13 -18.39 -19.59 -24.49 -20.83 -26.49 -25.89 -17.51 -10.73 -20.46 -24.53 -35.58 -33.94 -47.68 -51.68 -47.60 -28.64 -51.05 -61.37 -75.98 -90.65 -76.79 -64.21 -52.21 -38.84 -34.55 -24.42 -14.14 -15.34 -11.02 2.22 3.79 15.26 12.64 -7.58 -9.48 -10.89 -8.32 - - - - - - - - - -

Current Ratio

21.9 22.1 29.3 26.2 19.4 17.8 21.9 23.1 34.2 37.4 34.4 26.0 17.1 15.5 20.2 10.6 10.6 10.6 10.6 2.6 2.6 2.6 2.6 6.4 6.4 6.4 6.4 4.5 4.5 4.5 4.5 18.8 18.8 18.8 18.8 21.9 21.9 21.9 21.9 6.0 6.0 6.0 6.0 1.8 1.8 - - - - - - - - - -

DSO

- - - - - - - - 1730.3 463.7 29.6 - 34.6 164.1 72.0 - 25.4 12.4 17.0 - 21.2 - - - - - - 2498.0 151.4 2664.5 1819.3 48.5 44.2 44.2 39.1 8.9 6.7 7.1 6.0 4.0 1.5 3.7 6.0 7.2 1.9 - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - 1730.3 463.7 29.6 - 34.6 164.1 72.0 - 25.4 12.4 17.0 - 21.2 - - - - - - 2498.0 151.4 2664.5 1819.3 48.5 44.2 44.2 39.1 8.9 6.7 7.1 6.0 4.0 1.5 3.7 6.0 7.2 1.9 - - - - - - - - - -

Finanzkreislauf

- - - - - - - - 1730.3 463.7 29.6 - 34.6 164.1 72.0 - 25.4 12.4 17.0 - 21.2 - - - - - - 2498.0 151.4 2664.5 1819.3 48.5 44.2 44.2 39.1 8.9 6.7 7.1 6.0 4.0 1.5 3.7 6.0 7.2 1.9 - - - - - - - - - -

Alle Zahlen in USD-Währung